Healthtech Startups

Merative is a data, analytics, and technology partner serving healthcare organizations including providers, employers, payers, and government agencies. The company provides clinical decision support, data management, imaging solutions, and analytics platforms to help healthcare enterprises become insights-driven organizations.

1 investor

Merck Animal Health develops, manufactures and markets veterinary medicines, vaccines, animal identification products and monitoring services for the prevention, treatment and control of disease in companion animals and livestock. It serves veterinarians, pet owners, cattle/dairy producers and other animal caretakers worldwide.

1 investor

Meridian Medical Management provides revenue cycle management and healthcare analytics services to physician groups and medical practices, helping them optimize cash flow and reduce costs. The company serves over 40,000 healthcare providers and processes more than $4B in healthcare services annually.

1 investor

Meridio provides health benefit plans for small and growing businesses across the US, with affordable plan options, enrollment handling, and year-round support. It offers nationwide coverage with no minimum requirements and includes a team-facing hub for employees to review plans and enroll.

1 investor

Meril designs and manufactures medical devices across areas including vascular and peripheral intervention, cardiac surgery, orthopedics, endo-surgery, ENT, urology, diagnostics, and surgical robotics for hospitals, clinicians, and surgeons. Its products are made in-house in India and distributed internationally, with its ENT line present in more than 50 countries.

1 investor

MerLion Pharma is a pharmaceutical company engaged in the non-clinical and clinical development of drug candidates. It operates in the biotechnology and drug discovery industry.

1 investor

Mesenbio develops extracellular vesicle (EV) therapeutics derived from mesenchymal stem cells, using its FT-01 platform to enable scalable, GMP-ready EV manufacturing for regenerative medicine. The company is advancing a licensing-ready production platform and preclinical therapeutic candidate (MEV-N01) targeting rheumatoid arthritis.

1 investor

MESI Medical builds the MESI mTABLET, an integrated wireless diagnostic system that combines diagnostic modules, patient data, clinical decision support, and EHR connectivity on a single device for exams such as ABI, TBI, ECG, blood pressure, and spirometry. It serves healthcare professionals across settings including primary care, hospitals, and home visits.

1 investor

Mespere LifeSciences develops non-invasive medical devices for monitoring cardiac and cerebral hemodynamics in patients. It operates in the medical device and patient monitoring sector.

1 investor

META-BIOMED manufactures biodegradable surgical sutures, dental products, and bone restoration materials for orthopedic applications, serving healthcare providers globally. The company operates as a technology-intensive medical device manufacturer with products exported to over 80 countries.

1 investor

Metabelly produces prebiotic dietary fiber supplements made from corn starch that support healthy gut microbiota and digestive function. The product is marketed as a neutral-tasting daily fiber source for consumers seeking to maintain gut health and satiety.

1 investor

Metabolic sells a grass-fed whey protein powder supplement formulated with collagen peptides and electrolytes, marketed for fitness, recovery, and general wellness. The product is positioned as a premium alternative to mass-market protein powders, sourced from hormone- and antibiotic-free Australian cows.

1 investor

Metabolic Insights (Mii) has developed a rapid, non-invasive insulin test designed to measure metabolic markers without lab work or a separate reader. The product targets consumers seeking at-home insight into their metabolism and metabolic health.

1 investor

MetaGen provides personalized healthcare approaches based on gut microbiome analysis using proprietary metabologenomics methods. The company develops services and products that enable individuals to optimize their health by understanding and managing their unique gut microbiome composition.

1 investor

Metacarpal builds body-powered, multi-articulating upper-limb prosthetic hands designed to be waterproof, durable, and reliable without charging. Its devices serve prosthetic users and are supplied through clinicians and prosthetists.

1 investor

metaLead develops medications for treating metal-related diseases using chelation therapy, targeting improved patient quality of life. The company aims to establish its therapies as first-line treatments for various conditions.

1 investor

MetalloBio is an antimicrobials development company creating a new class of metal-based, broad-spectrum antibacterial agents to treat drug-resistant "superbug" infections. Its lead KLS-1 series targets complicated infections while its KLS-2 series is tuned for antimicrobial coatings on medical equipment such as catheters and joint implants.

1 investor

metasThera develops drugs targeting metastatic cancer cells by focusing on the cancer-specific plasma membrane citrate transporter pmCiC, which plays a role in cancer metabolism and adaptation.

1 investor

Metavention is developing a treatment that targets the sympathetic nervous system to disrupt overactive nerves believed to contribute to high blood pressure and other metabolic diseases. The company works on a medical intervention for hypertension and related metabolic conditions.

1 investor

Method Surgical AI develops an ultrasound imaging platform for surgical guidance that uses AI to generate real-time 3D subsurface maps for surgeons, designed to improve outcomes in robotic and minimally invasive cancer surgery.

1 investor

METHYS Dx develops liquid biopsy tests based on panels of methylation markers to characterize circulating tumor DNA (ctDNA) in biological fluids such as blood. Its tests target several common cancers to support disease prognosis, monitor tumor progression, and detect recurrences early, positioned as a lower-cost alternative to NGS testing.

1 investor

Metimedi Pharmaceuticals is a South Korean biopharmaceutical company developing calcium-based "booster" drugs, with a focus on refractory metastatic colorectal cancer and enhancing the efficacy of chemotherapy agents. It builds a research-driven pipeline for the pharmaceutical and healthcare industry.

1 investor

METLiT develops AI for MR Spectroscopy that automatically analyzes MRI spectrum data through collaborating agents to perform preprocessing, quantification, and clinical interpretation of brain metabolites. The company targets medical institutions and pharmaceutical clinical trials, making molecular-level diagnostic information from MRI accessible without specialized expert analysis.

1 investor

Metric Medical Devices develops internal bone fixation implants designed to accelerate healing and reduce non-union complications in orthopedic extremity procedures.

1 investor